Janux Therapeutics Correlations

JANX Stock  USD 29.94  0.49  1.61%   
The current 90-days correlation between Janux Therapeutics and Mineralys Therapeutics, Common is 0.11 (i.e., Average diversification). The correlation of Janux Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Janux Therapeutics Correlation With Market

Weak diversification

The correlation between Janux Therapeutics and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.

Moving together with Janux Stock

  0.83CDIOW Cardio DiagnosticsPairCorr
  0.84ELVN Enliven TherapeuticsPairCorr
  0.85SCLX Scilex HoldingPairCorr
  0.86ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.88CDIO Cardio DiagnosticsPairCorr
  0.95CRNX Crinetics PharmaceuticalsPairCorr
  0.82MSFT MicrosoftPairCorr

Moving against Janux Stock

  0.86WM Waste ManagementPairCorr
  0.84LUCD Lucid DiagnosticsPairCorr
  0.82GE GE AerospacePairCorr
  0.7PLX Protalix BiotherapeuticsPairCorr
  0.41PG Procter GamblePairCorr
  0.89JNJ Johnson JohnsonPairCorr
  0.85T ATT Inc Earnings Call TomorrowPairCorr
  0.84MMM 3M CompanyPairCorr
  0.78CVX Chevron CorpPairCorr
  0.72CSCO Cisco SystemsPairCorr
  0.71IBM International BusinessPairCorr
  0.64XOM Exxon Mobil CorpPairCorr
  0.55INTC IntelPairCorr
  0.31DD Dupont De NemoursPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
MNOVRZLT
MOLNRZLT
MNOVMOLN
MNOVKROS
HRMYRZLT
MNOVEWTX
  
High negative correlations   
MOLNMLYS
RZLTMLYS
MOLNFENC
FENCKROS
HRMYKROS
MNOVFENC

Risk-Adjusted Indicators

There is a big difference between Janux Stock performing well and Janux Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Janux Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MLYS  4.29  0.63  0.17 (0.45) 4.26 
 10.04 
 50.53 
ELYM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ANEB  5.72  0.62  0.10  0.37  5.70 
 19.58 
 40.87 
RZLT  3.07 (0.48) 0.00 (0.58) 0.00 
 5.62 
 22.04 
KROS  2.63 (0.73) 0.00  9.16  0.00 
 4.41 
 19.64 
FENC  2.06  0.26  0.08  0.14  2.93 
 4.75 
 16.33 
EWTX  2.92 (0.07) 0.00 (0.12) 0.00 
 5.32 
 26.44 
HRMY  1.98  0.23  0.07  0.17  2.96 
 4.36 
 17.63 
MOLN  2.72 (0.28) 0.00 (0.21) 0.00 
 7.84 
 20.58 
MNOV  2.24 (0.39) 0.00 (0.58) 0.00 
 5.35 
 16.27 

Janux Therapeutics Corporate Management

Brenda VreeswykHead ResourcesProfile
Zachariah DOChief OfficerProfile
Wayne MDChief OfficerProfile
Matt WhitmireVice FinanceProfile
Charles WinterManufacturing ChemistryProfile
CFA CPAActing OfficerProfile
Andy MeyerChief OfficerProfile